EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
批准号:
7672237
负责人:
GERALD Sanders BERENSON
金额:
$60.62万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-05-15 至 2011-08-31
关键词:
AffectAgeAgingAging-Related ProcessBinding ProteinsBiological AgingBiological MarkersBirth WeightBlood PressureC-reactive proteinCardiacCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemChildChildhoodCohort StudiesCommunitiesComplexDataDatabasesDimensionsDiseaseDoctor of MedicineEnvironmental Risk FactorEvolutionFamily history ofFamily memberFemaleFibrinogenGeneticGenomicsGestational AgeGlucoseGrantHeartHomocysteineHomocystineIndividualInflammationInsulinInsulin-Like Growth Factor IIntercellular adhesion molecule 1Interleukin-6Left ventricular structureLengthLeukocytesLifeLipoproteinsLongevityLow Birth Weight InfantMeasuresMediator of activation proteinMetabolic Syndrome XMetabolic syndromeMonitorMorbidity - disease rateNatural HistoryObesityOutcome MeasureOxidative StressPhysiologic pulsePlasminogen InactivatorsPopulationPredisposing FactorPredispositionPremature MortalityPrevention strategyProcessRaceRecording of previous eventsResearchResourcesRiskRisk FactorsSomatic CellStructureTimeVariantadiponectinage effectbasebody systembrachial arterycardiovascular risk factorcohortdimorphismheart dimension/sizein uteroindexingmalemiddle agemortalitynormal agingprematuresexual dimorphismtelomeretrait
中文摘要
描述(申请人提供):心血管(C-V)系统是最受衰老影响的重要器官系统。就动脉和心脏结构/功能(C-V指数)而言,C-V衰老的自然历史是由内在(生物)衰老效应和生命早期开始的C-V危险因素负担之间的复杂相互作用决定的。这项更新应用的重点是与C-V衰老相关的病理生物学特征,在一个以社区为基础的黑人-白人中年队列中,从童年开始随访超过30年。具体目的是:1)继续监测C-V指数在实足年龄、C-V危险因素变量负担、C-V风险和寿命家族特征方面的进展;2)通过染色体端粒动力学确定C-V指数变化与生物衰老的关系;3)考察出生体重对儿童期C-V危险因素变量负担的影响及C-V指标不良变化率。为了实现这些目标,在上一个赠款期间跟踪的正在进行的研究队列(队列1,n= 1200)和10年前儿童时期检查的另一个队列(队列2,n= 1200)可用。除了端粒动力学、出生体重和亚临床C-V指数外,还将收集与C-V衰老相关的选定关键变量的数据,特别是代谢综合征的风险变量,包括炎症和氧化应激。两组患者将通过颈动脉IMT、左心室结构和功能、肱动脉顺应性和动脉脉搏波速度来检查C-V指数;2) C-V危险因素变量,包括肥胖指标、血压、脂蛋白变量、葡萄糖、胰岛素和氧化应激参数;3)端粒长度。此外,将在队列I中获得出生体重、脂联素、胰岛素样生长因子-1及结合蛋白、同型半胱氨酸、纤维蛋白原、纤溶酶原激活物抑制剂-1、c反应蛋白、白细胞介素-6和细胞间粘附分子-1的数据;队列1中儿童期至成年期端粒磨损率及C-V风险和寿命的家族特征。Bogalusa心脏研究的广泛序列数据库提供了独特而宝贵的资源。本研究的结果将进一步了解双种族中青年人群C-V老化和影响衰老的易感因素。从这项研究中得出的观察结果将有助于制定有效的预防策略,以缓和影响过早C-V发病率和死亡率的介质。
英文摘要
DESCRIPTION (provided by applicant): The cardiovascular (C-V) system is a vital organ system most affected by the aging process. The natural history of C-V aging in terms of arterial and cardiac structure/function (C-V indices) is governed by a complex interplay between an intrinsic (biologic) aging effect and a burden of C-V risk factors beginning early in life. This renewal application focuses on the pathobiological traits associated with C-V aging in a community-based, black-white, middle-aged cohort having been followed over 30 years beginning in childhood. The specific aims are to 1) continue monitoring the progression of C-V indices with respect to chronological age, the burden of C-V risk factor variables and familial traits of C-V risk and longevity; 2) determine the relationship between changes in C-V indices and biological aging ascertained by chromosomal telomere dynamics; 3) examine the influence of birth weight on the burden of C-V risk factor variables since childhood and the rate of adverse changes in C-V indices. The ongoing study cohort followed during the previous grant period (Cohort I, n=1,200) and an additional cohort examined as children 10 years ago (Cohort II, n=1,200) are available to achieve these aims. In addition to telomere dynamics, birth weight, and subclinical C-V indices, data on selected key variables relevant to C-V aging, in particular risk variables of metabolic syndrome including inflammation and oxidative stress will be collected. Both cohorts will be examined for 1) C-V indices by carotid IMT, left ventricular structure and function, brachial artery compliance, and arterial pulse wave velocity; 2) C-V risk factor variables comprising obesity measures, blood pressure, lipoprotein variables, glucose, insulin, and parameters of oxidative stress; and 3) telomere length. In addition, data on birth weight, adiponectin, insulin like growth factor-I and binding proteins, homocysteine, fibrinogen, plasminogen activator inhibitor-I, C-reactive protein, interleukin-6, and intercellular adhesion molecule-1 will be obtained in Cohort I; telomere attrition rate from childhood to adulthood and familial traits of C-V risk and longevity in Cohort I1. The extensive serial database of the Bogalusa Heart Study provides unique and valuable resources. Findings from the proposed research will further the understanding of C-V aging and predisposing factors that influence aging in a bi-racial young to middle age population. Observations derived from this research will help develop effective preventive strategies to temper mediators that influence premature C-V morbidity and mortality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evolution of Cardiovascular Risk with Normal Aging
-
批准号:8436938
-
项目类别:
-
资助金额:$93.57万
-
财政年份:2012
-
负责人:GERALD Sanders BERENSON
-
依托单位:
Evolution of Cardiovascular Risk with Normal Aging
-
批准号:8723711
-
项目类别:
-
资助金额:$89.26万
-
财政年份:2012
-
负责人:GERALD Sanders BERENSON
-
依托单位:
Evolution of Cardiovascular Risk with Normal Aging
-
批准号:8548213
-
项目类别:
-
资助金额:$88.15万
-
财政年份:2012
-
负责人:GERALD Sanders BERENSON
-
依托单位:
Evaluation of Cardiovascular Health Among Residents
-
批准号:7044023
-
项目类别:
-
资助金额:$2.16万
-
财政年份:2003
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:6372298
-
项目类别:
-
资助金额:$71.34万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:7119557
-
项目类别:
-
资助金额:$77.55万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:7288588
-
项目类别:
-
资助金额:$5.12万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:7918134
-
项目类别:
-
资助金额:$55.19万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:6792730
-
项目类别:
-
资助金额:$85.21万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:7489425
-
项目类别:
-
资助金额:$73.8万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:6053741
-
项目类别:
-
资助金额:$71.58万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:6866003
-
项目类别:
-
资助金额:$79.82万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:6643372
-
项目类别:
-
资助金额:$95.18万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:7277676
-
项目类别:
-
资助金额:$75.3万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
-
批准号:6509618
-
项目类别:
-
资助金额:$69.76万
-
财政年份:2000
-
负责人:GERALD Sanders BERENSON
-
依托单位:
Evolution of Cardiovascular Risk with Normal Aging
-
批准号:6570716
-
项目类别:
-
资助金额:$14.85万
-
财政年份:1999
-
负责人:GERALD Sanders BERENSON
-
依托单位:
CHILDHOOD PREDICTOR OF ADULT CORONARY ARTERY DISEASE
-
批准号:2205190
-
项目类别:
-
资助金额:$38.31万
-
财政年份:1994
-
负责人:GERALD Sanders BERENSON
-
依托单位:
CHILDHOOD PREDICTOR OF ADULT CORONARY ARTERY DISEASE
-
批准号:2205188
-
项目类别:
-
资助金额:$22.64万
-
财政年份:1994
-
负责人:GERALD Sanders BERENSON
-
依托单位:
CHILDHOOD PREDICTOR OF ADULT CORONARY ARTERY DISEASE
-
批准号:2403431
-
项目类别:
-
资助金额:$40.46万
-
财政年份:1994
-
负责人:GERALD Sanders BERENSON
-
依托单位:
CHILDHOOD PREDICTOR OF ADULT CORONARY ARTERY DISEASE
-
批准号:2673788
-
项目类别:
-
资助金额:$29.13万
-
财政年份:1994
-
负责人:GERALD Sanders BERENSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: